Home

SANDRA A. GARDINER

CIK 1218574 · CFO & EVP Admin. and Finance · last filed 2026-08-12

SANDRA A. GARDINER is a CFO & EVP Admin. and Finance who has filed 16 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ADGM, was dated Aug 12, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

16

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
CUTERA, INC.
3240 BAYSHORE BOULEVARD
BRISBANE, CA 94005
Formerly Known As
GARDINER SANDRA (2003–2018)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADGM Director — $0.56 — $0 2 2026-08-12
Lucira Health, Inc. (LHDX) Delisted Director — $0.45 — $0 1 2022-06-03
PLSE CFO & EVP Admin. and Finance — $53.11 — $0 3 2022-02-28
CUTERA INC (CUTR) Delisted EVP & Chief Financial Officer 31,161 $0.10 $3.0K $0 6 2019-02-14
Aspira Women's Health Inc. (VRML) Delisted VP & Chief Financial Officer 24,000 — — $0 2 2011-03-22
LIPID SCIENCES INC/ (LIPD) Delisted Chief Financial Officer — — — $0 2 2007-12-05

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 ADGM Grant (A) — $0 EDGAR
2025-03-21 ADGM Grant (A) — $0 EDGAR
2022-06-03 Lucira Health, Inc. (LHDX) Delisted Grant (A) — $0 EDGAR
2022-02-28 PLSE Grant (A) — $0 EDGAR
2021-03-24 PLSE Grant (A) — $0 EDGAR
2019-11-19 PLSE Grant (A) — $0 EDGAR
2019-02-14 CUTERA INC (CUTR) Delisted Grant (A) +18,128 $0 EDGAR
2019-01-03 CUTERA INC (CUTR) Delisted Mixed +1,058 -$28.5K EDGAR
2018-12-17 CUTERA INC (CUTR) Delisted Tax (F) −704 -$11.6K EDGAR
2018-12-04 CUTERA INC (CUTR) Delisted Tax (F) −442 -$9.1K EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.